A detailed history of Charles Schwab Investment Management Inc transactions in Seer, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 353,640 shares of SEER stock, worth $594,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares
353,640
Previous 329,430 7.35%
Holding current value
$594,115
Previous $639,000 5.01%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$1.54 - $2.09 $37,283 - $50,598
24,210 Added 7.35%
353,640 $671,000
Q4 2023

Feb 06, 2024

BUY
$1.47 - $2.22 $5,350 - $8,080
3,640 Added 1.12%
329,430 $639,000
Q3 2023

Nov 08, 2023

SELL
$2.18 - $5.52 $13,653 - $34,571
-6,263 Reduced 1.89%
325,790 $719,000
Q2 2023

Aug 09, 2023

BUY
$3.16 - $4.96 $132,422 - $207,853
41,906 Added 14.44%
332,053 $1.42 Million
Q1 2023

May 11, 2023

BUY
$3.6 - $5.88 $27,626 - $45,123
7,674 Added 2.72%
290,147 $1.12 Million
Q4 2022

Feb 13, 2023

SELL
$5.03 - $8.58 $73,593 - $125,533
-14,631 Reduced 4.92%
282,473 $1.64 Million
Q3 2022

Nov 14, 2022

BUY
$7.7 - $13.31 $54,092 - $93,502
7,025 Added 2.42%
297,104 $2.3 Million
Q2 2022

Aug 15, 2022

BUY
$6.72 - $16.07 $131,624 - $314,763
19,587 Added 7.24%
290,079 $2.6 Million
Q1 2022

May 13, 2022

BUY
$11.88 - $23.4 $90,513 - $178,284
7,619 Added 2.9%
270,492 $4.12 Million
Q4 2021

Feb 11, 2022

BUY
$21.08 - $38.51 $85,142 - $155,541
4,039 Added 1.56%
262,873 $6 Million
Q3 2021

Nov 16, 2021

BUY
$27.67 - $45.04 $4.55 Million - $7.41 Million
164,527 Added 174.46%
258,834 $8.94 Million
Q2 2021

Aug 16, 2021

BUY
$28.75 - $56.92 $91,195 - $180,550
3,172 Added 3.48%
94,307 $3.09 Million
Q1 2021

May 17, 2021

BUY
$38.67 - $84.06 $3.52 Million - $7.66 Million
91,135 New
91,135 $4.56 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $98.4M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.